Welcome to our dedicated page for InfuSystem Holdings news (Ticker: INFU), a resource for investors and traders seeking the latest updates and insights on InfuSystem Holdings stock.
InfuSystem Holdings, Inc. (NYSE American: INFU) is a growing healthcare service provider specializing in delivering infusion pumps and related products and services to patients across the United States and Canada. The company is headquartered in Rochester Hills, Michigan, and operates from five strategically located facilities to ensure comprehensive coverage. InfuSystem facilitates outpatient care through a two-platform model: Patient Services and Device Solutions.
Patient Services offers a last-mile solution for clinic-to-home healthcare. This segment includes Oncology, Pain Management, Wound Therapy, and Lymphedema services. It focuses on delivering complex durable medical equipment directly to patients, ensuring they receive continuous care at home or other non-hospital settings.
Device Solutions supports the Patient Services platform by providing direct payer rentals, pump and consumable sales, and biomedical services and repair. This segment's goal is to enhance service orientation and secure additional business from its direct payer clients.
InfuSystem's innovative approach and strategic partnerships have made it a leader in the healthcare service sector. Recently, the company announced a sales and marketing partnership with Dignitana AB, a leader in scalp cooling technology. This collaboration allows InfuSystem to offer the FDA-cleared DigniCap Scalp Cooling System to help minimize hair loss for cancer patients undergoing chemotherapy. This partnership highlights InfuSystem's commitment to enhancing patient care and expanding its product offerings.
InfuSystem boasts a robust financial position, underpinned by its diversified service offerings and strong market presence. The company continues to explore new opportunities to grow and enhance its service delivery, ensuring that it remains at the forefront of the healthcare industry.
InfuSystem Holdings, Inc. (NYSE American: INFU) will announce its full year 2021 annual financial guidance on December 15, 2020, prior to market opening. A conference call for investors will occur at 9:00 a.m. Eastern Time on the same day to discuss the guidance and business developments. Interested participants can join via phone or through a live webcast on the company’s website. InfuSystem specializes in providing outpatient care solutions for manufacturers and healthcare providers under two platforms: Integrated Therapy Services and Durable Medical Equipment Services.
InfuSystem Holdings, a prominent health care service provider, announced that CEO Rich DiIorio and CFO Barry Steele will present at key investor conferences on November 17 and 19, 2020. The conferences include the Craig-Hallum Capital Group 11th Annual Alpha Select Conference and the Sidoti & Company Virtual Microcap Conference. A presentation at the latter is scheduled for 2:30 p.m. ET, with a webcast available on InfuSystem's investor relations website. The company focuses on outpatient care for durable medical equipment, serving sectors like oncology and pain management.
InfuSystem Holdings reported robust Q3 2020 financial results, with net revenues of $25.1 million, representing a 17% increase compared to the previous year. Net income surged by 159% to $2.9 million, while Adjusted EBITDA rose 46% to $7.5 million. The company has raised its full-year guidance to estimated revenues of $96 million - $97 million and Adjusted EBITDA of $26 million - $27 million. Strong performance was driven by increased demand in oncology and a growing market for infusion pumps due to COVID-19, leading to improved operating cash flow and profitability.
InfuSystem Holdings, Inc. (NYSE American: INFU) will release its third quarter 2020 financial results on November 12, 2020, before market opening. The company will host a conference call for investors at 9:00 a.m. Eastern Time on the same day to discuss the results. Interested participants can join via phone or a live webcast available on the company’s website. InfuSystem specializes in outpatient care, particularly through its Integrated Therapy Services and Durable Medical Equipment Services platforms.
InfuSystem Holdings to Present at Sidoti’s Fall 2020 Investor Conference
Rochester Hills, Michigan, Sept. 14, 2020 – InfuSystem (NYSE American: INFU) announced that CEO Richard DiIorio and CFO Barry Steele will present at Sidoti's Fall 2020 Investor Conference on September 23 at 3:15 p.m. ET via a virtual platform. The presentation will be available on InfuSystem's website. Additionally, the management will hold one-on-one meetings with investors on September 23-24. InfuSystem is a prominent national health care service provider, specializing in outpatient care for durable medical equipment.
InfuSystem Holdings, a national health care service provider focused on outpatient care, announced CEO Richard DiIorio and CFO Barry Steele will present at Lake Street's 4th Annual Best Ideas Growth (BIG4) Conference on September 17, 2020. The event will be held virtually, featuring one-on-one and group meetings with investors throughout the day. InfuSystem operates through Integrated Therapy Services and Durable Medical Equipment Services, ensuring comprehensive support for durable medical equipment.
InfuSystem Holdings, Inc. (NYSE American: INFU) announces its participation in the LD 500 Virtual Conference on September 1, 2020, at 9:40 a.m. ET. Richard DiIorio, CEO, and Barry Steele, CFO, will present at the event, which runs from September 1 to 4. InfuSystem is a national health care service provider specializing in outpatient care and durable medical equipment. Their services are divided into Integrated Therapy Services and Durable Medical Equipment Services, supporting various health care needs. More details can be found on their website.
InfuSystem Holdings reported record revenues of $26 million for Q2 2020, marking a 32% year-over-year increase. The net income surged to $4.1 million, up from $0.4 million last year, reflecting a tenfold growth. Adjusted EBITDA also rose significantly, reaching $8.5 million, an 87% increase. The company reestablished its full-year guidance, projecting revenues between $94 million and $97 million and adjusted EBITDA between $23 million and $26 million. However, management cautioned that the elevated demand driven by COVID-19 may not persist.
InfuSystem Holdings, Inc. (NYSE American: INFU) will release its second-quarter 2020 financial results on August 13, 2020, prior to market opening. A conference call for investors is scheduled for the same day at 9:00 a.m. Eastern Time to discuss the financial results. The call can be accessed by dialing (833) 366-1127 or via live webcast on the Company's website. InfuSystem is a national provider of infusion pumps and durable medical equipment services, serving hospitals and clinics across the U.S. and Canada.
InfuSystem Holdings, Inc. (NYSE American: INFU) announced its inclusion in the FTSE Russell 2000® Index, effective after market close on June 26, 2020. This milestone is expected to enhance the company's visibility among institutional investors, as stated by CEO Richard DiIorio. InfuSystem, a provider of infusion pumps and related support services, aims to build on its operational success and expand into new therapies. The Russell 2000® Index is a key benchmark for small-cap companies, covering a significant portion of the market.
FAQ
What is the current stock price of InfuSystem Holdings (INFU)?
What is the market cap of InfuSystem Holdings (INFU)?
What services does InfuSystem Holdings, Inc. provide?
What are the two platforms of InfuSystem's services?
Where is InfuSystem Holdings, Inc. headquartered?
Who are InfuSystem's recent partners?
What is the DigniCap Scalp Cooling System?
What areas does InfuSystem serve?
What is the objective of the Patient Services platform?
How does the Device Solutions platform support InfuSystem?
What are InfuSystem's business segments?
How does InfuSystem contribute to patient care?
